New York State Common Retirement Fund boosted its holdings in shares of Azenta, Inc. (NASDAQ:AZTA – Free Report) by 41.0% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 265,983 shares of the company’s stock after buying an additional 77,409 shares during the quarter. New York State Common Retirement Fund owned 0.58% of Azenta worth $13,299,000 as of its most recent SEC filing.
Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Farther Finance Advisors LLC raised its stake in shares of Azenta by 20.0% in the third quarter. Farther Finance Advisors LLC now owns 1,537 shares of the company’s stock valued at $74,000 after acquiring an additional 256 shares in the last quarter. QRG Capital Management Inc. increased its holdings in Azenta by 6.6% during the 3rd quarter. QRG Capital Management Inc. now owns 6,156 shares of the company’s stock worth $298,000 after purchasing an additional 383 shares during the period. Ballentine Partners LLC raised its position in Azenta by 2.0% in the 4th quarter. Ballentine Partners LLC now owns 20,340 shares of the company’s stock valued at $1,017,000 after purchasing an additional 404 shares in the last quarter. Glenmede Trust Co. NA boosted its stake in shares of Azenta by 6.3% in the 3rd quarter. Glenmede Trust Co. NA now owns 11,379 shares of the company’s stock valued at $551,000 after buying an additional 679 shares during the period. Finally, KBC Group NV grew its position in shares of Azenta by 48.5% during the fourth quarter. KBC Group NV now owns 2,137 shares of the company’s stock worth $107,000 after buying an additional 698 shares in the last quarter. Hedge funds and other institutional investors own 99.08% of the company’s stock.
Azenta Stock Down 0.1 %
Shares of AZTA opened at $44.75 on Monday. The company has a market capitalization of $2.05 billion, a price-to-earnings ratio of -15.02 and a beta of 1.47. Azenta, Inc. has a 52-week low of $38.82 and a 52-week high of $67.77. The stock has a 50 day moving average price of $50.45 and a 200 day moving average price of $48.00.
Analysts Set New Price Targets
AZTA has been the topic of several analyst reports. Needham & Company LLC raised their target price on shares of Azenta from $55.00 to $59.00 and gave the company a “buy” rating in a report on Thursday, February 6th. Evercore ISI raised their price objective on shares of Azenta from $50.00 to $52.00 and gave the company an “in-line” rating in a report on Thursday, February 6th. Finally, Stephens reiterated an “overweight” rating and set a $60.00 target price on shares of Azenta in a research note on Thursday, January 2nd.
Check Out Our Latest Report on Azenta
Azenta Profile
Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.
Recommended Stories
- Five stocks we like better than Azenta
- How to trade using analyst ratings
- Why Genuine Parts Company Is a Royally Good Buy Right Now
- What is a Stock Market Index and How Do You Use Them?
- Industrials Are Quietly Outpacing the Market: 3 Stocks to Watch
- 3 Monster Growth Stocks to Buy Now
- These 5 Energy Stocks Hedge Inflation With Growth Potential
Receive News & Ratings for Azenta Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Azenta and related companies with MarketBeat.com's FREE daily email newsletter.